BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 30161253)

  • 21. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
    Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
    Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases.
    Holmes CL; Shim D; Kernien J; Johnson CJ; Nett JE; Shelef MA
    J Immunol Res; 2019; 2019():2160192. PubMed ID: 30993117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning.
    Badillo-Soto MA; Rodríguez-Rodríguez M; Pérez-Pérez ME; Daza-Benitez L; Bollain-Y-Goytia JJ; Carrillo-Jiménez MA; Avalos-Díaz E; Herrera-Esparza R
    Eur J Rheumatol; 2016 Jun; 3(2):44-49. PubMed ID: 27708970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
    Vossenaar ER; Radstake TR; van der Heijden A; van Mansum MA; Dieteren C; de Rooij DJ; Barrera P; Zendman AJ; van Venrooij WJ
    Ann Rheum Dis; 2004 Apr; 63(4):373-81. PubMed ID: 15020330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
    Damgaard D; Senolt L; Nielsen CH
    Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis.
    Sokolove J; Brennan MJ; Sharpe O; Lahey LJ; Kao AH; Krishnan E; Edmundowicz D; Lepus CM; Wasko MC; Robinson WH
    Arthritis Rheum; 2013 Jul; 65(7):1719-24. PubMed ID: 23553485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
    Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
    Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4).
    Hollingsworth TJ; Radic MZ; Beranova-Giorgianni S; Giorgianni F; Wang Y; Iannaccone A
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3808-3815. PubMed ID: 30073354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients.
    Janssen KMJ; de Smit MJ; Withaar C; Brouwer E; van Winkelhoff AJ; Vissink A; Westra J
    J Clin Periodontol; 2017 Jun; 44(6):577-584. PubMed ID: 28370244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Citrullinated Protein Antibodies With Multiple Specificities Ameliorate Collagen Antibody-Induced Arthritis in a Time-Dependent Manner.
    Gomez AM; Brewer RC; Moon JS; Acharya S; Kongpachith S; Wang Q; Jahanbani S; Wong HH; Lanz TV; Love ZZ; Min-Oo G; Niedziela-Majka A; Robinson WH
    Arthritis Rheumatol; 2024 Feb; 76(2):181-191. PubMed ID: 37610274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
    Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
    Front Immunol; 2018; 9():2696. PubMed ID: 30515171
    [No Abstract]   [Full Text] [Related]  

  • 32. Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4.
    Yoshida K; Ito H; Kurosaka D; Ikeda R; Noda K; Saito M; Kurosaka D
    Sci Rep; 2023 May; 13(1):7528. PubMed ID: 37160933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
    Curran AM; Naik P; Giles JT; Darrah E
    Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia induces production of citrullinated proteins in human fibroblast-like synoviocytes through regulating HIF1α.
    Yu R; Li C; Sun L; Jian L; Ma Z; Zhao J; Liu X
    Scand J Immunol; 2018 Apr; 87(4):e12654. PubMed ID: 29484680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation.
    Cîrciumaru A; Afonso MG; Wähämaa H; Krishnamurthy A; Hansson M; Mathsson-Alm L; Keszei M; Stålesen R; Ottosson L; de Vries C; Shelef MA; Malmström V; Klareskog L; Catrina AI; Grönwall C; Hensvold A; Réthi B
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?
    Balandraud N; Auger I; Roudier J
    J Autoimmun; 2021 Jan; 116():102542. PubMed ID: 32928608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
    Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
    Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
    Vitkov L; Hannig M; Minnich B; Herrmann M
    Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis.
    Massarenti L; Enevold C; Damgaard D; Hansen PR; Frisch M; Ødum N; Jacobsen S; Nielsen CH
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.